Author:
Khouri Olivia R.,Frey Melissa K.,Musa Fernanda,Muggia Franco,Lee Jessica,Boyd Leslie,Curtin John P.,Pothuri Bhavana
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Cancer Research,Pharmacology,Toxicology,Oncology
Reference10 articles.
1. Howlader N, Noone AM, Krapcho M, Miller D, Bishop K, Kosary CL, Yu M, Ruhl J,Tatalovich Z, Mariotto A, Lewis DR, Chen HS, Feuer EJ, Cronin KA (eds) SEER Cancer Statistics Review, 1975–2014. National Cancer Institute. Bethesda, MD.
https://seer.cancer.gov/csr/1975_2014/
, based on November 2016 SEER data submission, posted to the SEER web site, April 2017
2. Vergote I, De Wever I, Tjalma W, Van Gramberen M, Decloedt J, Van Dam P (1998) Neoadjuvant chemotherapy or primary debulking surgery in advanced ovarian carcinoma: a retrospective analysis of 285 patients. Gynecol Oncol 71:431–436
3. Chambers JT, Chambers SK, Voynick IM, Schwartz PE (1990) Neoadjuvant chemotherapy in stage X ovarian carcinoma. Gynecol Oncol 37:327–331
4. Wright AA et al (2016) Neoadjuvant chemotherapy for newly diagnosed, advanced ovarian cancer: Society of Gynecologic Oncology and American Society of Clinical Oncology Clinical Practice Guideline. Gynecol Oncol 143(1):3–15
5. Amant F, Moerman P, Neven P, Timmerman D, Van Limbergen E, Vergote I (2005) Endometrial cancer. Lancet 366:591–605
Cited by
33 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献